News

According to a study, an inexpensive anti-seizure medication markedly improves learning, memory and other cognitive functions in Alzheimer’s patients who have epileptic activity in their brains.

Researchers have successfully revived human heart tissue after it was preserved in a subfreezing, supercooled state.

Researchers have discovered the working mechanism of potential drug targets for various diseases such as cancer and inflammatory diseases.

A non-profit, open-science consortium, The COVID Moonshot, has received funding of £8 million from Wellcome, on behalf of the Covid-19 Therapeutics Accelerator. In addition to addressing the current COVID-19 pandemic, the consortium plans to develop one or more novel pan-coronavirus antiviral molecules to combat future outbreaks.

New research has shown why some drugs in clinical trials for treating a form of acute myeloid leukemia (AML) often fail and has demonstrated a way to restore their effectiveness.

UCLA Jonsson Comprehensive Cancer Center researcher Dr. Alice Soragni has received a $2.5 million grant to develop lab-grown mini tumors that can help to identify treatments for rare neuroendocrine cancers.

A research team has identified a new gene as a cause of an inherited heart condition that affects one in 500 people.

For advanced cancers, integrated DNA analyses may help pinpoint overlooked mechanisms that cancer cells use to metastasize, which may be promising targets for therapy development.

A platform has been developed to allow scientists to grow virtual tumors. It also harnesses artificial intelligence to optimize the design of nanoparticles to treat them.

A research project has been awarded a Breast Cancer Research Program Breakthrough grant from the US Department of Defense and aims to bring novel therapies from the laboratory bench to the help of patients suffering from metastatic breast cancer.